Ashley Cordova Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Ashley Cordova has an estimated net worth of at least $12.0 million*, as of Dec. 18, 2024. They own 220,465 shares of NVCR stock. They have sold 41,655 shares of NVCR stock since 2021, for an estimated $4.8 million.
Ashley Cordova $NVCR SEC Form 4 Insider Trading
Ashley Cordova has filed a total of 17 insider trades in $NVCR since 2021. Their most recent trade was a sale of 688 shares, made on Aug 02, 2024. Their largest trade was a sale of 8,026 shares, made on Aug 12, 2021. We estimate that they now own 220,465 shares of $NVCR, worth an estimated $7.3 million.
Insider Trading at $NVCR
There have been a total of 151 insider trades reported at $NVCR since 2021, with 4,974 shares purchased and 542,412 shares sold. The most active insider traders in $NVCR stock have been Frank X Leonard, Frank X Leonard, and Ashley Cordova. The most recent trade was a sale of 44 shares reported by Mukund Paravasthu (Chief Operating Officer), made on Nov 02, 2024.
History of Insider Stock Trades by Ashley Cordova
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NVCR
|
Sale | 688 | Aug 02, 2024 | Aug. 5, 2024, 4:25 p.m. |
|
NVCR
|
Sale | 883 | Sep 01, 2023 | Sept. 5, 2023, 4:24 p.m. |
|
NVCR
|
Sale | 1,144 | Aug 02, 2023 | Aug. 4, 2023, 4:02 p.m. |
|
NVCR
|
Sale | 775 | Mar 03, 2023 | March 7, 2023, 5:51 p.m. |
|
NVCR
|
Sale | 4,730 | Mar 03, 2023 | March 7, 2023, 5:51 p.m. |
|
NVCR
|
Sale | 1,055 | Mar 02, 2023 | March 6, 2023, 5:40 p.m. |
|
NVCR
|
Sale | 2,198 | Mar 01, 2023 | March 2, 2023, 5:55 p.m. |
|
NVCR
|
Sale | 885 | Sep 02, 2022 | Sept. 6, 2022, 5:15 p.m. |
|
NVCR
|
Sale | 759 | Mar 08, 2022 | March 9, 2022, 5:51 p.m. |
|
NVCR
|
Sale | 1,149 | Mar 03, 2022 | March 7, 2022, 7:26 p.m. |
|
NVCR
|
Sale | 556 | Mar 04, 2022 | March 7, 2022, 7:26 p.m. |
|
NVCR
|
Sale | 209 | Nov 02, 2021 | Nov. 2, 2021, 8 p.m. |
|
NVCR
|
Sale | 2,767 | Aug 12, 2021 | Aug. 15, 2021, 8 p.m. |
|
NVCR
|
Sale | 5,927 | Aug 12, 2021 | Aug. 15, 2021, 8 p.m. |
|
NVCR
|
Sale | 8,026 | Aug 12, 2021 | Aug. 15, 2021, 8 p.m. |
|
NVCR
|
Sale | 2,606 | Aug 12, 2021 | Aug. 15, 2021, 8 p.m. |
|
NVCR
|
Sale | 7,298 | Aug 12, 2021 | Aug. 15, 2021, 8 p.m. |
$NVCR Executives and Stock Owners with Insider Trades
-
Frank X Leonard, Chief Development Officer
-
Frank X Leonard, President, CNS Cancers US
-
Ashley Cordova, Chief Financial Officer
-
Asaf Danziger, Chief Executive Officer
-
Wilhelmus Cm Groenhuysen, Chief Operating Officer
-
Pritesh Shah, Chief Commercial Officer
-
Ely Benaim, Chief Medical Officer
-
William Patrick Burke, Chief Human Resources Officer
-
Pritesh Shah, Chief Growth Officer
-
Frank X Leonard, EVP, Pres., Novocure Oncology
-
Uri Weinberg, Chief Science Officer
-
Todd Christopher Longsworth, General Counsel
-
William F Doyle, Executive Chairman
-
Mukund Paravasthu, Chief Operating Officer
-
Michal Nath Puri, Chief Human Resources Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.